Interview with Harvard stem cell researcher

01/24/2006 |

The New York Times published a Q-and-A with Harvard Stem Cell Institute researcher Douglas Melton, who is conducting privately funded research on a cure for Type 1 diabetes. Melton discusses ethical concerns, the South Korean stem cell scandal, federal funding and other issues surrounding embroynic stem cell research.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care